# Oncopeptides – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/oncopeptides
Company JSON: https://spela.port0.org/company/oncopeptides/company.json
Documents JSON: https://spela.port0.org/company/oncopeptides/documents.json
Updated: 2026-08-07T06:12:59Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/oncopeptides/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/oncopeptides/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/oncopeptides/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/oncopeptides/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/oncopeptides/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/oncopeptides/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/oncopeptides/reports
- JSON: https://spela.port0.org/company/oncopeptides/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=ba63c728cd2dc5f5244354cfbe38d3551&lang=en&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=b59e2f33e874bdad672aac3a861f27e35&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b39c83566f4cd28de866c50e1fc3b8419&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b3ed817c232647a7306ed557fd1247346&lang=en&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b3341027f6cbd0253df72b48fce2f79cf&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=bbee942e56623baa793739e2e2e09f2f6&lang=en&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b0ca885f7156672f7cb4a5e25da46b360&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b7726cd82bed86c978145f2c163d6d9d5&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b88749bc5de7afa92caff80b7ea0317fe&lang=en&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=be6857c6667761c38a1e3ff2e7906fdf6&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=ba64a2f0da65156ccf492300a0568f195&lang=en&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=ba0b3d56c00e10d1b5c1dbb3166308f1e&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b6fe088cb2d97713ccf378257a58a514e&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b494cb61055f22fb7b563672e017a49ab&lang=en&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=bc3b23b1ef100c2d078949d341a6b0417&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b0ab52e703a4b7a0195a3d4299da0e1ef&lang=en&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/oncopeptides/finansinspektionen
- Summary: https://spela.port0.org/company/oncopeptides/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/oncopeptides/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/oncopeptides/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/oncopeptides/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/oncopeptides/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/oncopeptides/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/oncopeptides/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt